Sorry i could not resist my favourite quote for the conf call....

Sorry i could not resist my favourite quote for the conf call. What an awesome statement.... A $1.5Bn market growing at 20% PER YEAR and we are going to take our product which has "somewhat unlimited potential" and completely disrupt the market!!!!!!!!

So sorry if I mention anything already stated on the thread these are the highlights for me from my notes.

I have been harping on these issues for weeks and I am so glad my feel for what Sanofi are up to has been publicly recognised. Ive read their reports many times and they are nervous about their current dominance and what will happen when the Generics hit the market. Now we know the answer.

The key message from this conf call is the statement and following questions on the future strategy of our strategic partner Sanofi

Generics will attack Sanofi's key drugs with their cheaper copies, how does Sanofi protect their market dominance ????? They will put their product in a fully integrated safety device. The only one on the market !!!!!!!!!!!! to differentiate them and allow them to continue to dominate the markets.

Shareholders this is why we are building a 1bn unit facility, this is what our business is about selling syringes , new drugs will take time to build up numbers even though they must order our product before the drugs are released. The key driver for us is to ramp up production so we can generate revenue!!! We achieve this by putting our product into the market place holding Sanofis top selling products now!!!! This is amazing for me and considering sanofi use 850M units today for the prefill market imagine what it will mean in the very short term for our revenue projections
Sorry it just such a amazing outcome for our business Im over the moooooooooooooooooooon

Now a few other milestones being achieved

Clean rooms commence install in April OMG how good is that !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

The Sanofi agreement ending Jun 2014, for the first time I could see what that ment strategically. They have to sign up by then and commit to a 10 year commercial quantity order for that drug class People thats why people like Mr Buffett buy Pharma stocks 10 years of contracted commercial orders.. Thats where the USA PE ratios start to work magic numbers.

Pipeline. Just amazing, 150 drugs in the pipeline, 3ml and 5 ml and the disruptive technology of our products plus plus the unimaginable potential of the Select product for the Vaccine market.

Cost factors for our customers are clear.
Savings of 60-70% in packaging
50 to 70% in transport
60 to 70% in warehouse

So in Summary from the top down

Europe implements laws along with the USA to require the use of our type of product.
We have an exclusive agreement with the worlds #1 user of prefill syringes (850 m units) and vaccine product (1.6bn doses)
They have to sign 10 year commercial agreements with us to supply product by June 2014
Our product reduces their key costs by an average of 50-60%
Our pipeline products are all now on the go in the research areas
We have a near monopoly position in a multibillion dollar market with huge barriers to entry
We have the cash in the bank
We have a partner looking to replace its current orders in its biggest drug lines to protect its market position by using our product

No wonder those Gorillas are all wondering around in disbelief!!!!! Soon I think its going to get nasty and at the moment they are in denial the penny will drop when the factory opens.

In summary

potential is somewhat unlimited